Bisphosphonates for men with prostate cancer: sifting through the rubble

Long-term oncological outcomes of bladder cancer: a population-based study with a 25-year follow-up.

BJU international·2025

Unplanned hospitalization among advanced prostate cancer patients by diabetes status: a population-based study.

JNCI cancer spectrum·2025

Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer.

Cancers·2025

The Association between Tea Consumption and Bladder Cancer Risk Based on the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) International Consortium.

Nutrition and cancer·2025

Contemporary outcomes for robotic radical cystectomy and intracorporeal neobladder urinary diversion.

Urologic oncology·2025

Effects of a Phytoestrogen Intervention and Estrogen Receptor β Genotype on Prostate Cancer Proliferation and PSA Concentrations-A Randomized Controlled Trial.

Nutrition and cancer·2024

Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Pearls and pitfalls of oral carbapenem/penem agents: the promise of a new era or the risk of amplified resistance?

Expert opinion on pharmacotherapy·2026

Frailty and low body mass index as key determinants of sodium-glucose cotransporter 2 inhibitor-specific adverse event-related discontinuation in adults aged ≥75 years: A multicenter real-world retrospective cohort study.

Journal of diabetes investigation·2026

Bayesian Hierarchy model for population pharmacokinetics of amikacin in Japanese clinical population.

Journal of biopharmaceutical statistics·2026

Comparative neuroprotective effects of antidiabetic medications on Parkinson's disease risk: a Bayesian network meta-analysis.

Journal of global health·2026

Examine the effects of the developed Pender's model constructs on medication compliance and adherence to a low-salt diet in patients with uncontrolled hypertension.

Journal of education and health promotion·2026

Glucagon-like receptor-1 agonists and impotence: A meta-analysis.

World journal of methodology·2026

Related Experiment Videos

Bisphosphonates for men with prostate cancer: sifting through the rubble

Related Concept Videos

Long-term oncological outcomes of bladder cancer: a population-based study with a 25-year follow-up.

Unplanned hospitalization among advanced prostate cancer patients by diabetes status: a population-based study.

Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer.

The Association between Tea Consumption and Bladder Cancer Risk Based on the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) International Consortium.

Contemporary outcomes for robotic radical cystectomy and intracorporeal neobladder urinary diversion.

Effects of a Phytoestrogen Intervention and Estrogen Receptor β Genotype on Prostate Cancer Proliferation and PSA Concentrations-A Randomized Controlled Trial.

Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.

Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.

Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.

COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

Pearls and pitfalls of oral carbapenem/penem agents: the promise of a new era or the risk of amplified resistance?

Frailty and low body mass index as key determinants of sodium-glucose cotransporter 2 inhibitor-specific adverse event-related discontinuation in adults aged ≥75 years: A multicenter real-world retrospective cohort study.

Bayesian Hierarchy model for population pharmacokinetics of amikacin in Japanese clinical population.

Comparative neuroprotective effects of antidiabetic medications on Parkinson's disease risk: a Bayesian network meta-analysis.

Examine the effects of the developed Pender's model constructs on medication compliance and adherence to a low-salt diet in patients with uncontrolled hypertension.

Glucagon-like receptor-1 agonists and impotence: A meta-analysis.

Related Experiment Videos

Bisphosphonates for men with prostate cancer: sifting through the rubble

Related Concept Videos

Related Articles